publication . Article . Conference object . 2019

Functional carbon quantum dots as medical countermeasures to human coronavirus (HCoV)

Łoczechin, Aleksandra; Séron, Karin; Barras, Alexandre; Giovanelli, Emerson; Belouzard, Sandrine; Chen, Yen-Ting; Metzler-Nolte, Nils; Boukherroub, Rabah; Dubuisson, Jean; Szunerits, Sabine;
Open Access English
  • Published: 20 Nov 2019
  • Publisher: HAL CCSD
  • Country: France
International audience; Therapeutic options for the highly pathogenic human coronavirus (HCoV) infections are urgently needed. Anti-coronavirus therapy is however challenging, as coronaviruses are biologically diverse and rapidly mutating. In this work, the antiviral activity of seven different carbon quantum dots (CQDs) for the treatment of human coronavirus HCoV-229E infections was investigated. The first generation of antiviral CQDs was derived by hydrothermal carbonization from ethylenediamine/citric acid as carbon precursors and post-modified with boronic acid ligands. These nanostructures showed a concentration dependent virus inactivation with an estimate...
Persistent Identifiers
Medical Subject Headings: virus diseases
free text keywords: human coronavirus (HCoV), carbon quantum dots (CQDs), antiviral therapy, boronic acid, multivalent interactions, [SDV]Life Sciences [q-bio], human coronavirus (HCoV);carbon quantum dots (CQDs);antiviral therapy;boronic acid;multivalent interactions, General Materials Science, Highly pathogenic, Carbon quantum dots, Human coronavirus, Antiviral therapy, Materials science, Virology
Communities with gateway
OpenAIRE Connect image
Funded by
Pathogen and Graphene
  • Funder: European Commission (EC)
  • Project Code: 690836
  • Funding stream: H2020 | MSCA-RISE
18 references, page 1 of 2

574 (1) Nii-Trebi, N. I. Emerging and Neglected Infectious Diseases: 575 Insights, Advances, and Challenges. BioMed Res. Int. 2017, 2017, 1−15.

576 (2) report-prioritization.pdf (accessed 16 September 2019).

578 (3) Al Hajjar, S.; Ziad A. Memish, Z. A.; McIntosh, K. Middle East 579 Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual 580 Challenge. Ann. Saudi Med. 2013, 33, 427−436.

581 (4) cov/mers-situation-update-november-2017.html (accessed 16 Septem583 ber 2019).

584 (5) Mo, Y.; Fisher, D. A Review of Treatment Modalities Of Middle 585 Repsiratorey Syndroms. J. Antimicrob. Chemother. 2016, 71, 3340− 586 3350.

587 (6) Uyeki, T. M.; Erlandson, K. J.; Korch, G.; O'Hara, M.; Wathen, 588 M.; Hu-Primmer, J.; Hojvat, S.; Stemmy, E. J.; Donabedian, A.

589 Development of Medical Countermeasures to Middle East Respiratory 590 Syndrome Coronavirus. Emerging Infect. Dis. 2016, 22, 1−6.

591 (7) Zumla, A.; Chan, J. F. W.; Azhar, E. I.; Hui, D. S. C.; Yuen, K.-Y.

592 Coronavirus-Drug Discovery and Therapeutic Options. Nat. Rev. Drug 593 Discovery 2016, 15, 327−347.

594 (8) Du, L.; Yang, Y.; Zhou, Y.; Lu, L.; Li, F.; Jiang, S. MERS-Cov Spike 595 Protein: A Key Target for Antivirals. Expert Opin. Ther. Targets 2017, 596 21, 131−143.

597 (9) Lu, L.; Liu, Q.; Zhu, Y.; Chan, K.-H.; Qin, L.; Li, Y.; Wang, Q.; 598 Chan, J. F. W.; Du, L.; Yu, F.; Ma, C.; Ye, S.; Yuen, K.-Y.; Zhang, R.; 599 Jiang, S. Structures-Based Discovery Of Middle East Repiratory 600 Syndrome Coronavirus Fusion Inhibitor. Nat. Commun. 2014, 5 601 (3067), 1−15.

602 (10) Szunerits, S.; Barras, A.; Khanal, M.; Pagneux, Q.; Boukherroub, 603 R. Nanostructures for the Inhibition of Viral Infections. Molecules 2015, 604 20, 14051−14081. [OpenAIRE]

605 (11) Lim, S. Y.; Shen, W.; Gao, Z. Carbon Quantum Dots And Their 606 Applications. Chem. Soc. Rev. 2015, 44, 362−381.

607 (12) Barras, A.; Pagneux, Q.; Sane, F.; Wang, Q.; Boukherroub, R.; 608 Hober, D.; Szunerits, S. High Efficiency of Functional Carbon 609 Nanodots as Entry Inhibitors of Herpes Simplex Virus Type 1. ACS 610 Appl. Mater. Interfaces 2016, 8, 9004−9013.

611 (13) Fahmi, M. Z.; Sukmayani, W.; Qamariyah Khairunisa, S.; 612 Witaningrum, A. M.; Indriati, D. W.; Matondang, M. Q. Y.; Chang, J.- 613 Y.; Kotaki, T.; Kameokaf, M. Design of boronic acid-attributed carbon 614 dots on inhibits HIV-1 entry. RSC Adv. 2016, 6, 92996−93002.

18 references, page 1 of 2
Any information missing or wrong?Report an Issue